Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Dist...

FDA Recall #D-0257-2024 — Class III — December 26, 2023

Recall #D-0257-2024 Date: December 26, 2023 Classification: Class III Status: Ongoing

Product Description

Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC 68084-214-01; Individual Dose NDC 68084-214-11

Reason for Recall

Superpotent drug: Assay results were slightly above specification at the time zero point.

Recalling Firm

Amerisource Health Services LLC — Columbus, OH

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

6,344 cartons

Distribution

Nationwide in the USA

Code Information

Lot # 1014208, Exp Mar/31/2025

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated